Rekah Pharmaceutical (Israel) Volatility
| REKA Stock | ILA 1,422 16.00 1.11% |
At this point, Rekah Pharmaceutical is very steady. Rekah Pharmaceutical maintains Sharpe Ratio (i.e., Efficiency) of 0.004, which implies the firm had a 0.004% return per unit of risk over the last 3 months. We have found twenty-four technical indicators for Rekah Pharmaceutical, which you can use to evaluate the volatility of the company. Please check Rekah Pharmaceutical's Coefficient Of Variation of (3,616), variance of 11.94, and Risk Adjusted Performance of (0.01) to confirm if the risk estimate we provide is consistent with the expected return of 0.0135%. Key indicators related to Rekah Pharmaceutical's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Rekah Pharmaceutical Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Rekah daily returns, and it is calculated using variance and standard deviation. We also use Rekah's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Rekah Pharmaceutical volatility.
Rekah |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Rekah Pharmaceutical can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Rekah Pharmaceutical at lower prices to lower their average cost per share. Similarly, when the prices of Rekah Pharmaceutical's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Rekah Pharmaceutical Market Sensitivity And Downside Risk
Rekah Pharmaceutical's beta coefficient measures the volatility of Rekah stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Rekah stock's returns against your selected market. In other words, Rekah Pharmaceutical's beta of -0.33 provides an investor with an approximation of how much risk Rekah Pharmaceutical stock can potentially add to one of your existing portfolios. Rekah Pharmaceutical Industry exhibits very low volatility with skewness of -0.13 and kurtosis of 0.35. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Rekah Pharmaceutical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Rekah Pharmaceutical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Rekah Pharmaceutical Demand TrendCheck current 90 days Rekah Pharmaceutical correlation with market (Dow Jones Industrial)Rekah Beta |
Rekah standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 3.37 |
It is essential to understand the difference between upside risk (as represented by Rekah Pharmaceutical's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Rekah Pharmaceutical's daily returns or price. Since the actual investment returns on holding a position in rekah stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Rekah Pharmaceutical.
Rekah Pharmaceutical Stock Volatility Analysis
Volatility refers to the frequency at which Rekah Pharmaceutical stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Rekah Pharmaceutical's price changes. Investors will then calculate the volatility of Rekah Pharmaceutical's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Rekah Pharmaceutical's volatility:
Historical Volatility
This type of stock volatility measures Rekah Pharmaceutical's fluctuations based on previous trends. It's commonly used to predict Rekah Pharmaceutical's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Rekah Pharmaceutical's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Rekah Pharmaceutical's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Rekah Pharmaceutical Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Rekah Pharmaceutical Projected Return Density Against Market
Assuming the 90 days trading horizon Rekah Pharmaceutical Industry has a beta of -0.3251 indicating as returns on the benchmark increase, returns on holding Rekah Pharmaceutical are expected to decrease at a much lower rate. During a bear market, however, Rekah Pharmaceutical Industry is likely to outperform the market.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Rekah Pharmaceutical or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Rekah Pharmaceutical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Rekah stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Rekah Pharmaceutical Industry has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Rekah Pharmaceutical Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Rekah Pharmaceutical Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of Rekah Pharmaceutical is 24953.57. The daily returns are distributed with a variance of 11.34 and standard deviation of 3.37. The mean deviation of Rekah Pharmaceutical Industry is currently at 2.53. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | -0.33 | |
σ | Overall volatility | 3.37 | |
Ir | Information ratio | -0.07 |
Rekah Pharmaceutical Stock Return Volatility
Rekah Pharmaceutical historical daily return volatility represents how much of Rekah Pharmaceutical stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company accepts 3.3676% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7716% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Rekah Pharmaceutical Volatility
Volatility is a rate at which the price of Rekah Pharmaceutical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Rekah Pharmaceutical may increase or decrease. In other words, similar to Rekah's beta indicator, it measures the risk of Rekah Pharmaceutical and helps estimate the fluctuations that may happen in a short period of time. So if prices of Rekah Pharmaceutical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Rekah Pharmaceutical Industry Ltd. engages in the manufacture, marketing, sale, and distribution of prescription and OTC drugs, dermo-cosmetics, vitamins, and nutritional supplements in Israel. The company was founded in 1941 and is based in Holon, Israel. REKAH PHARMA operates under Drug ManufacturersSpecialty Generic classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 9 people.
Rekah Pharmaceutical's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Rekah Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Rekah Pharmaceutical's price varies over time.
3 ways to utilize Rekah Pharmaceutical's volatility to invest better
Higher Rekah Pharmaceutical's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Rekah Pharmaceutical stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Rekah Pharmaceutical stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Rekah Pharmaceutical investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Rekah Pharmaceutical's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Rekah Pharmaceutical's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Rekah Pharmaceutical Investment Opportunity
Rekah Pharmaceutical Industry has a volatility of 3.37 and is 4.38 times more volatile than Dow Jones Industrial. 29 percent of all equities and portfolios are less risky than Rekah Pharmaceutical. You can use Rekah Pharmaceutical Industry to protect your portfolios against small market fluctuations. The stock experiences a somewhat bearish sentiment, but the market may correct it shortly. Check odds of Rekah Pharmaceutical to be traded at 1379.34 in 90 days.Good diversification
The correlation between Rekah Pharmaceutical Industry and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rekah Pharmaceutical Industry and DJI in the same portfolio, assuming nothing else is changed.
Rekah Pharmaceutical Additional Risk Indicators
The analysis of Rekah Pharmaceutical's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Rekah Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some common measures of Rekah Pharmaceutical stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | 0.3347 | |||
| Mean Deviation | 2.56 | |||
| Coefficient Of Variation | (3,616) | |||
| Standard Deviation | 3.46 | |||
| Variance | 11.94 | |||
| Information Ratio | (0.07) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Rekah Pharmaceutical Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Rekah Pharmaceutical as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Rekah Pharmaceutical's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Rekah Pharmaceutical's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Rekah Pharmaceutical Industry.
Complementary Tools for Rekah Stock analysis
When running Rekah Pharmaceutical's price analysis, check to measure Rekah Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rekah Pharmaceutical is operating at the current time. Most of Rekah Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Rekah Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rekah Pharmaceutical's price. Additionally, you may evaluate how the addition of Rekah Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |